Condition: Carbon Ion Radiotheray · High-grade Glioma · Heavy Ion Radiotherapy · Sponsor: Gansu Wuwei Tumor Hospital
The objective is to use the advantages of heavy ion physical dosimetry and biology to improve the tumor control rate and long-term survival rate of high-grade glioma, reduce the occurrence of brain tissue radiation damage caused by increasing prescription dose, and provide new treatment suggestions for glioma radiotherapy.
This description comes directly from the study's public registry record.
Xiaojun Li · +8613150160200 · anglweli@qq.com
Always discuss trial participation with your own doctor first.
| Heavy Ion Radiotherapy Department | Wuwei, Gansu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06831773